Q: What is Farxiga used for?

Farxiga is used to treat: type 2 diabetes mellitus heart failure chronic kidney disease

Q: How does Farxiga work?

Mechanism of Action Farxiga works by targeting a specific protein in the kidneys known as sodium-glucose co-transporter 2 (SGLT2). Under normal conditions, the kidneys filter sugar from the blood and then use this protein to absorb it back into the body. By blocking SGLT2, Farxiga prevents this reabsorption process. When the protein is blocked, the following occurs: Glucose removal: Excess sugar stays in the urine rather than returning to the blood and is eliminated from the body during urination. Blood sugar reduction: Because the sugar is being removed through the urine, the overall level of glucose in the blood decreases. Sodium and fluid balance: The medication also increases the amount of sodium and water filtered out of the body. By increasing the removal of sodium and water, Farxiga can help reduce the volume of fluid in the bloodstream. This action may help lower the strain on the heart and reduce pressure within the filtering units of the kidneys, which can be beneficial for individuals with certain heart or kidney conditions.

Q: What are the active ingredients in Farxiga?

The active ingredient in Farxiga is dapagliflozin .

Q: What are the side effects of Farxiga?

Common side effects of Farxiga may include: urinary tract infection genital yeast infection increased urination Always consult with a healthcare professional about potential side effects.

Q: What drug class is Farxiga?

Farxiga belongs to the SGLT2 inhibitor drug class.

Q: What is the dosage of Farxiga and how do I take it?

How to Take Farxiga Farxiga is a tablet taken by mouth. It is usually taken once a day in the morning. You may take this medication with or without food. It is important to take Farxiga exactly as directed by your healthcare provider. Try to take your dose at the same time every day to maintain a consistent level of the medication in your body. Tablets should be swallowed whole; do not crush, chew, or break them. Missed Dose If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at the same time to make up for a missed one.

Q: Is Farxiga safe during pregnancy and breastfeeding?

Pregnancy Farxiga is not recommended for use during the second and third trimesters of pregnancy. Research in animal studies has shown that the medication may interfere with the development and maturation of the fetal kidneys. If you are pregnant or planning to become pregnant, discuss the risks and benefits of your treatment options with your healthcare provider. If you discover you are pregnant while taking Farxiga, contact your doctor right away. They will help determine if you should stop the medication and switch to a different treatment to manage your condition during pregnancy. Breastfeeding It is currently unknown if Farxiga passes into human breast milk. However, because the drug may pose a risk to the developing kidneys of a nursing infant, healthcare providers generally advise against breastfeeding while taking this medication. You should talk to your doctor about the best way to feed your baby if you need to take Farxiga.

Q: What forms and strengths does Farxiga come in?

Farxiga is available in the following form: Oral Tablet: These are film-coated tablets intended to be swallowed whole. The tablets are available in different shapes and colors to distinguish between different versions of the medication. No other forms, such as liquids or injections, are currently available for this drug.

Q: What is the FDA approval status of Farxiga?

FDA Approval and Indications Farxiga (dapagliflozin) was first approved by the U.S. Food and Drug Administration (FDA) in 2014. It is currently approved for several specific uses in adults: Improving blood sugar control in people with type 2 diabetes, when used alongside diet and exercise. Reducing the risk of hospitalization for heart failure in adults with type 2 diabetes who also have cardiovascular disease or multiple cardiovascular risk factors. Treating heart failure in adults with reduced ejection fraction to lower the risk of cardiovascular death and hospitalization. Reducing the risk of kidney function decline, end-stage kidney disease, and cardiovascular death in adults with chronic kidney disease at risk of progression. Safety Communications and Label Changes The FDA has issued several safety communications and required label updates for Farxiga and other drugs in the SGLT2 inhibitor class due to identified risks: Ketoacidosis: The FDA revised labels to include warnings about the risk of ketoacidosis, a serious condition where the blood becomes too acidic. This condition can occur even if blood sugar levels are not highly elevated. Serious Urinary Tract Infections: Warnings were added regarding the risk of severe urinary tract infections, including urosepsis and pyelonephritis, which may lead to hospitalization. Fournier’s Gangrene: In 2018, the FDA warned about a rare but life-threatening bacterial infection of the genital area, known as necrotizing fasciitis of the perineum or Fournier’s gangrene, associated with SGLT2 inhibitors. Farxiga is not approved for the treatment of type 1 diabetes or for treating diabetic ketoacidosis.

Question 1

What is Farxiga?

Accepted Answer

Farxiga is a medication that helps the body lower blood sugar levels by assisting the kidneys in removing glucose through the urine. It works by blocking a specific protein in the kidneys, which prevents glucose from being reabsorbed into the bloodstream.

This medication is also used to support cardiovascular and kidney health. It is part of a therapeutic approach to managing metabolic and organ-related conditions by facilitating the excretion of excess sugar and salt from the body.

Question 2

What is Farxiga used for?

Accepted Answer

Farxiga is used to treat:

type 2 diabetes mellitus
heart failure
chronic kidney disease

Question 3

How does Farxiga work?

Accepted Answer

Mechanism of Action

Farxiga works by targeting a specific protein in the kidneys known as sodium-glucose co-transporter 2 (SGLT2). Under normal conditions, the kidneys filter sugar from the blood and then use this protein to absorb it back into the body. By blocking SGLT2, Farxiga prevents this reabsorption process.

When the protein is blocked, the following occurs:

Glucose removal: Excess sugar stays in the urine rather than returning to the blood and is eliminated from the body during urination.
Blood sugar reduction: Because the sugar is being removed through the urine, the overall level of glucose in the blood decreases.
Sodium and fluid balance: The medication also increases the amount of sodium and water filtered out of the body.

By increasing the removal of sodium and water, Farxiga can help reduce the volume of fluid in the bloodstream. This action may help lower the strain on the heart and reduce pressure within the filtering units of the kidneys, which can be beneficial for individuals with certain heart or kidney conditions.

Question 4

What are the active ingredients in Farxiga?

Accepted Answer

The active ingredient in Farxiga is dapagliflozin.

Question 5

What are the side effects of Farxiga?

Accepted Answer

Common side effects of Farxiga may include:

urinary tract infection
genital yeast infection
increased urination

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Farxiga?

Accepted Answer

Farxiga belongs to the SGLT2 inhibitor drug class.

Question 7

What is the dosage of Farxiga and how do I take it?

Accepted Answer

How to Take Farxiga

Farxiga is a tablet taken by mouth. It is usually taken once a day in the morning. You may take this medication with or without food.

It is important to take Farxiga exactly as directed by your healthcare provider. Try to take your dose at the same time every day to maintain a consistent level of the medication in your body. Tablets should be swallowed whole; do not crush, chew, or break them.

Missed Dose

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at the same time to make up for a missed one.

Question 8

Is Farxiga safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Farxiga is not recommended for use during the second and third trimesters of pregnancy. Research in animal studies has shown that the medication may interfere with the development and maturation of the fetal kidneys. If you are pregnant or planning to become pregnant, discuss the risks and benefits of your treatment options with your healthcare provider.

If you discover you are pregnant while taking Farxiga, contact your doctor right away. They will help determine if you should stop the medication and switch to a different treatment to manage your condition during pregnancy.

Breastfeeding

It is currently unknown if Farxiga passes into human breast milk. However, because the drug may pose a risk to the developing kidneys of a nursing infant, healthcare providers generally advise against breastfeeding while taking this medication. You should talk to your doctor about the best way to feed your baby if you need to take Farxiga.

Question 9

What forms and strengths does Farxiga come in?

Accepted Answer

Farxiga is available in the following form:

Oral Tablet: These are film-coated tablets intended to be swallowed whole.

The tablets are available in different shapes and colors to distinguish between different versions of the medication. No other forms, such as liquids or injections, are currently available for this drug.

Question 10

What is the FDA approval status of Farxiga?

Accepted Answer

FDA Approval and Indications

Farxiga (dapagliflozin) was first approved by the U.S. Food and Drug Administration (FDA) in 2014. It is currently approved for several specific uses in adults:

Improving blood sugar control in people with type 2 diabetes, when used alongside diet and exercise.
Reducing the risk of hospitalization for heart failure in adults with type 2 diabetes who also have cardiovascular disease or multiple cardiovascular risk factors.
Treating heart failure in adults with reduced ejection fraction to lower the risk of cardiovascular death and hospitalization.
Reducing the risk of kidney function decline, end-stage kidney disease, and cardiovascular death in adults with chronic kidney disease at risk of progression.

Safety Communications and Label Changes

The FDA has issued several safety communications and required label updates for Farxiga and other drugs in the SGLT2 inhibitor class due to identified risks:

Ketoacidosis: The FDA revised labels to include warnings about the risk of ketoacidosis, a serious condition where the blood becomes too acidic. This condition can occur even if blood sugar levels are not highly elevated.
Serious Urinary Tract Infections: Warnings were added regarding the risk of severe urinary tract infections, including urosepsis and pyelonephritis, which may lead to hospitalization.
Fournier’s Gangrene: In 2018, the FDA warned about a rare but life-threatening bacterial infection of the genital area, known as necrotizing fasciitis of the perineum or Fournier’s gangrene, associated with SGLT2 inhibitors.

Farxiga is not approved for the treatment of type 1 diabetes or for treating diabetic ketoacidosis.

Question 11

What should I know about Farxiga and cost?

Accepted Answer

Insurance and Pharmacy Pricing

The out-of-pocket cost for Farxiga is largely determined by your health insurance plan. Most Medicare Part D and private insurance plans cover the medication, but it is often classified as a preferred brand or non-preferred brand, which affects the copay amount. Prices may also vary between different retail pharmacies and mail-order services.

Generic Options

Dapagliflozin is the active ingredient in Farxiga. Although generic versions have received FDA approval, their availability in pharmacies can be limited by patent protections. When available, generic drugs generally offer a more affordable alternative to brand-name medications.

Ways to Save

There are several options that may help reduce the cost of Farxiga:

Manufacturer Savings Cards: Eligible patients with commercial insurance may be able to use a savings card from the manufacturer to lower their monthly copay.
Patient Assistance Programs: Individuals without insurance or those with limited financial resources may qualify for programs that provide the medication at a reduced cost or for free based on income requirements.
90-Day Supplies: Some insurance providers offer lower costs if the medication is purchased in a 90-day supply rather than a 30-day supply, particularly through mail-order pharmacy programs.

Farxiga

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Farxiga

Hospitals.net Disclosure